NCT07133906View on ClinicalTrials.gov

Accuracy of Interstitial Continuous Glucose Sensors in Neonates

Not yet recruitingOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Neonatal HypoglycemiaGestational DiabetesMaternal Obesity Complicating PregnancySmall-for-gestational AgeLarge-for-gestational Age
Interventions
DEVICE

Continuous glucose monitoring

A blinded Abbott Freestyle Libre 3 Pro will be placed on the newborn

DEVICE

Cerebral near-infrared spectroscopy

Blinded cerebral near infrared spectroscopy will be assessed

All Listed Sponsors
lead

Women and Infants Hospital of Rhode Island

OTHER